Up-to-date in pulmonary and extrapulmonary sarcoidosis

Acta Clinica Belgica

Volumn 63, Issue 6, 2008, Pages 408-413

  Valeyre, Dominique ^a,b   Uzunhan, Y ^a   Bouvry, D ^a   Naccache, J M ^a   Nunes, H ^a  

^a UNIVERSITÉ PARIS 13   (France)

^b AVICENNE HOSPITAL   (France)

Author keywords

Extrapulmonary sarcoidosis; Pulmonary sarcoidosis

Indexed keywords

ADALIMUMAB; ALEMTUZUMAB; ANTIHYPERTENSIVE AGENT; CORTICOSTEROID; ETANERCEPT; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

CD4+ T LYMPHOCYTE; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; ENVIRONMENTAL FACTOR; GENETIC PREDISPOSITION; GENOTYPE PHENOTYPE CORRELATION; HISTOPATHOLOGY; HUMAN; INCIDENCE; LUNG LAVAGE; MORTALITY; PATHOGENESIS; PHENOTYPE; PROGNOSIS; PULMONARY HYPERTENSION; SARCOIDOSIS;

EID: 57849168373     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2008.084     Document Type: Conference Paper

References (25)

1. Hosada Y, Sasagawa S, Yasuda N, Yamaguchi T. Epidemiology of sarcoidosis: general approach. Half-a-century of studies. In: Sarcoidosis, RP Baughman Ed., Taylor and Francis, New-York. 2006; 210: 13-46.
2. Thomeer M, Demedts M, Wuyts W. Epidemiology of sarcoidosis. In: Sarcoidosis, M Drent and U Costabel Ed., Eur Respir Monograph 2005; 10: 13-22.
3. Gribbin J, Hubbard RB, Le Jeune I, Smith CJP, West J, Tata LJ. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax 2006; 61: 980-5.
4. Morimoto T, Azuma A, Abe S, et al. Epidemiology of sarcoidosis in Japan. Eur Respir J 2008; 31: 372-9.
5. Hoffmann AL, Milman N, Byg KE. Childhood sarcoidosis in Denmark 1979-1994: incidence, clinical feature and laboratory results at presentation in 48 children. Acta Pediatr 2004; 93: 30-6.
6. Prasse A, Katic C, Germann M, Buhwald A, Zissel G, Müller-Quernheim J. Phenotyping sarcoidosis from a pulmonary perspective. Am J Respir Crit Care Med 2008; 177: 330-6.
7. Statement on sarcoidosis: joint statement of the ATS, ERS and WASOG. Am J Respir Crit Care Med 1999; 160: 735-55.
8. Grunewald J, Eklund A. Sex-specific manifestations of Löfgren's syndrome. Am J Respir Crit Care Med 2007; 175: 40-4.
9. Nunes H, Humbert M, Capron F, et al. Pulmonary hypertension associated with sarcoidosis. Thorax 2006; 61: 68-74.
10. Shorr AF, Helman DL, Davies DB, Nathan SD. Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics. Eur Respir J 2005; 25: 783-8.
11. Baughman RP. Pulmonary hypertension associated with sarcoidosis. Arthr Res Ther 2007; 9 (Suppl 2): S8.
12. Quaden C, Tillie-Leblond I, Delobbe A, Necrotising sarcoid granulomatosis: clinical, functional, endoscopical and radiographical evaluation. Eur Respir J 2005; 26: 778-85.
13. Hours S, Nunes H, Kambouchner M, et al. Pulmonary sarcoidosis: clinico-radiologic characteristics and natural history of a rare form of sarcoidosis. Medicine (Baltimore) 2008; 87: 142-51.
14. Baughman RP, Dent M, Kavuru M. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 2006; 174: 705-802.
15. Judson MA, Baughman RP, Costabel U, et al. Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur Respir J 2008; 31: 1189-96.
16. Aubart F, Ouayoun M, Brauner M, et al. Sino-nasal involvement of sarcoidoosis: a case control study of 20 cases. Medicine (Baltimore) 2006; 85: 365-71.
17. Bihan H, Christozova V, Dumas JL, et al. Sarcoidosis: clinical, hormonal, magnetic resonance imaging (MRI) manifestations of hypothalamo-pituitary disease in 9 patients and review of the literature. Medicine (Baltimore) 2007; 86: 259-68.
18. Bradley DA, Lower EE, Baughman RP. Diagnosis and management of spinal cord sarcoidosis. Sarcoidosis Vasc Int Lung Dis 2006; 23: 58-65.
19. Mehta D, Lubitz SA, Frankel J, et al. Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of out patient testing. Chest 2008; online.
20. Welker L, Jörres RA, Costabel U, Magnussen H. Predictive value of BAL cell differentiates in the diagnosis of interstitial lung diseases. Eur Respir J 2004; 24: 1000-6.
21. Wong M, Yasufuku K, Nakajuma T, et al. Endobronchial ultrasound: new insight for the diagnosis of sarcoidosis. Eur Respir J 2007; 29: 182-6.
22. Müller-Quernheim J, Gaede KI, Fireman E, Zissel G. Diagnoses of chronic beryllium disease with cohorts of sarcoidosis patients. Eur Respir J 2006; 27: 1190-5.
23. Arnold DF, Wiggins J, Cunningham-Rundles C, Misbah SA, Chapel HM. Granulomatous disease: distinguishing primary antibody disease from sarcoidosis. Clinical Immunology 2008; 128: 18-22.
24. Mclean-Tooke APC, Aldridge C, Gilmour K, Higgins B, Hudson M, Spickett GP. An unusual cause of granulomatous disease. BMC Clinical Pathology 2007; 7: 1.
25. Ramos-Casals M, Mana J, Nardi N, et al. Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases. Medicine (Baltimore) 2005; 64: 69-80.